Over-the-Counter Drugs to Be Sold in Japan’s Convenience Stores

The reform additionally contains new measures to handle the rising social situation of drug overdoses, notably amongst younger folks. To curb misuse, the legislation will introduce age-related restrictions on the acquisition of sure OTC medicines.

Japan’s regulation of prescription drugs dates again to the late nineteenth century, with the introduction of the “Regulations on Handling and Sales of Medicines” in 1889. This laid the groundwork for systematic management of drug security and efficacy. In 1943, in the course of the wartime interval, the Pharmaceutical Affairs Law (PAL) was enacted to carry a extra complete authorized framework to drug regulation. This legislation was overhauled in 1948 and once more in 1960 in response to postwar public well being wants and worldwide developments. The 1960 model, generally known as Law No. 145, grew to become the core authorized construction for drug and medical machine regulation in Japan for many years. It aimed to make sure the standard, efficacy, and security of prescription drugs, cosmetics, and medical units, and ruled their manufacture, sale, labeling, and commercial.

As medical expertise and worldwide regulatory requirements superior, so too did the necessity for Japan to modernize its pharmaceutical legal guidelines. One of probably the most important reforms got here in 2002, when the PAL was amended to introduce a risk-based classification system for medical units. This shift aligned Japan’s system extra intently with world norms and positioned better emphasis on post-marketing surveillance relatively than simply pre-approval inspections. The 2002 revision additionally acknowledged the rising complexity of biotechnology and the need of sustaining rigorous security protocols even after merchandise entered the market.

A decade later, in 2013, one other sweeping modification was made in response to the fast improvement of regenerative drugs and biologics. This modification launched a brand new class for regenerative medical merchandise and established a conditional, time-limited approval system that enabled earlier affected person entry to revolutionary therapies whereas nonetheless guaranteeing security via follow-up monitoring. In recognition of the broader scope of merchandise now lined by the laws, the legislation was renamed the Pharmaceuticals and Medical Devices Act (PMD Act). This revision marked a turning level by formally together with regenerative drugs underneath its jurisdiction, facilitating quicker innovation cycles and supporting Japan’s ambition to grow to be a pacesetter in superior medical expertise.

To assist the implementation and oversight of those adjustments, the Japanese authorities established the Pharmaceuticals and Medical Devices Agency (PMDA) in 2004. The PMDA grew to become the central physique answerable for product assessment, security monitoring, and post-market surveillance. It works in collaboration with the Ministry of Health, Labour and Welfare (MHLW) to make sure regulatory compliance and reply to rising public well being dangers. Over the years, the PMDA has grown in capability and worldwide presence, taking part in a key position in world drug security initiatives and harmonization efforts with counterparts such because the U.S. FDA and the European Medicines Agency.

The most up-to-date revision in May 2025 focuses on increasing shopper entry to over-the-counter (OTC) medicine whereas strengthening measures towards misuse, notably amongst younger folks. With the rise in convenience-focused retail and the rising social situation of drug overdoses amongst youth, the federal government amended the PMD Act to permit gross sales of OTC medicine in comfort shops, on the situation that consumers first obtain on-line explanations from licensed pharmacists. At the identical time, the modification introduces age-based restrictions on sure merchandise to handle issues over abuse.

Source: Kyodo